Interferon alfa-2a biosimilar (Amega Biotech)

干扰素α-2a生物类似药 (Amega Biotech)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInterferon alfa-2a biosimilar (Amega Biotech)

Drug Alias Name干扰素α-2a生物仿制药 (Amega Biotech)Interferon Alfa-2a biosimilar - Amega Biotech

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionN/A

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsLeukemia, Myelogenous, ChronicLeukemia, Hairy CellHepatitis C +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Clinical)

Highest Status in ChinaN/A

Originator CompaniesAmega Biotech

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAmega Biotech

Active IndicationsN/A

Inactive IndicationsLeukemia, Myelogenous, ChronicLeukemia, Hairy CellHepatitis C +[4]

ATC CodeL03AB04